Medpace Holdings, Inc. (MEDP)

409,65 +33,39 (+8,87%) Ab 03:40PM EDT. Markt geöffnet.

Medpace Holdings, Inc.

5375 Medpace Way
Cincinnati, OH 45227
United States
513 579 9911
https://www.medpace.com

Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 5.900

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. August James Troendle M.D.	Chairman & CEO	1,65M	N/A	1956
Mr. Jesse J. Geiger BBA, CPA	President	945,08k	N/A	1974
Mr. Kevin M. Brady	CFO & Treasurer	690,48k	1,64M	1975
Ms. Susan E. Burwig BSN, MA	Executive Vice President of Operations	1,12M	1,47M	1963
Mr. Stephen P. Ewald J.D.	Chief Compliance Officer, General Counsel & Corporate Secretary	914,64k	3,2M	1969
Brandon Ebken	Chief Information Officer	N/A	N/A	N/A
Ms. Lauren Morris	Associate Director of Investors Relations	N/A	N/A	N/A
Mr. Todd Meyers	Vice President of Business Development & Marketing	N/A	N/A	N/A
John T. Wynne MBA	Senior Vice President of Commercial Operations & Clinical Pharmacology Unit	N/A	N/A	N/A
Mr. Reinilde Heyrman M.D.	Chief Medical Officer of Medical Department	N/A	N/A	1961

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Corporate Governance

Medpace Holdings, Inc.s ISS Governance QualityScore, Stand 1. April 2024, lautet 7. Die grundlegenden Scores sind Audit: 4, Vorstand: 10, Shareholderrechte: 8, Kompensation: 5.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.